286 related articles for article (PubMed ID: 27797175)
1. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides.
Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W
ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175
[TBL] [Abstract][Full Text] [Related]
2. Myristic Acid-Modified
Ying M; Wang S; Zhang M; Wang R; Zhu H; Ruan H; Ran D; Chai Z; Wang X; Lu W
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19473-19482. PubMed ID: 29790744
[TBL] [Abstract][Full Text] [Related]
3. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
4. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
[TBL] [Abstract][Full Text] [Related]
5. Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.
Zhang Y; Zhai M; Chen Z; Han X; Yu F; Li Z; Xie X; Han C; Yu L; Yang Y; Mei X
Drug Deliv; 2017 Nov; 24(1):1045-1055. PubMed ID: 28687044
[TBL] [Abstract][Full Text] [Related]
6. Stabilized Heptapeptide A7R for Enhanced Multifunctional Liposome-Based Tumor-Targeted Drug Delivery.
Ying M; Shen Q; Liu Y; Yan Z; Wei X; Zhan C; Gao J; Xie C; Yao B; Lu W
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13232-41. PubMed ID: 27195531
[TBL] [Abstract][Full Text] [Related]
7. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.
Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H
J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054
[TBL] [Abstract][Full Text] [Related]
8. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
9. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
10. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
11. The influx/efflux mechanisms of d-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma.
Han B; Xie W; Zhang Y; Zhou S; Yang J; Wang R; Sun Y; Wang X; Xu J; Chen D; Wang Y; Lu J; Ning F; Shen F; Liu M; Cai H; Xin H; Lu W; Zhang X
J Control Release; 2020 Nov; 327():384-396. PubMed ID: 32791079
[TBL] [Abstract][Full Text] [Related]
12. Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide.
Wang H; Wang X; Xie C; Zhang M; Ruan H; Wang S; Jiang K; Wang F; Zhan C; Lu W; Wang H
J Control Release; 2018 Aug; 284():26-38. PubMed ID: 29885416
[TBL] [Abstract][Full Text] [Related]
13. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
[TBL] [Abstract][Full Text] [Related]
14. Glioma targeting peptide modified apoferritin nanocage.
Zhai M; Wang Y; Zhang L; Liang M; Fu S; Cui L; Yang M; Gong W; Li Z; Yu L; Xie X; Yang C; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1013-1024. PubMed ID: 29726297
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment.
Belhadj Z; Zhan C; Ying M; Wei X; Xie C; Yan Z; Lu W
Oncotarget; 2017 Sep; 8(40):66889-66900. PubMed ID: 28978003
[TBL] [Abstract][Full Text] [Related]
16. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
[TBL] [Abstract][Full Text] [Related]
17. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
[TBL] [Abstract][Full Text] [Related]
18. A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery.
Ruan H; Chai Z; Shen Q; Chen X; Su B; Xie C; Zhan C; Yao S; Wang H; Zhang M; Ying M; Lu W
J Control Release; 2018 Jun; 279():306-315. PubMed ID: 29679668
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.
Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q
ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814
[TBL] [Abstract][Full Text] [Related]
20. A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery.
Wei X; Zhan C; Shen Q; Fu W; Xie C; Gao J; Peng C; Zheng P; Lu W
Angew Chem Int Ed Engl; 2015 Mar; 54(10):3023-7. PubMed ID: 25600241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]